182 related articles for article (PubMed ID: 9634125)
1. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement.
Bell ND; King JA; Kusyk C; Nelson BP; Sendelbach KM
South Med J; 1998 Jun; 91(6):584-7. PubMed ID: 9634125
[TBL] [Abstract][Full Text] [Related]
2. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
Brink DS; Grosso LE; Dunphy CH
Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
[TBL] [Abstract][Full Text] [Related]
3. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
4. De novo CD5+ Burkitt lymphoma/leukemia.
Lin CW; O'Brien S; Faber J; Manshouri T; Romaguera J; Huh YO; Kantarjian H; Keating M; Albitar M
Am J Clin Pathol; 1999 Dec; 112(6):828-35. PubMed ID: 10587706
[TBL] [Abstract][Full Text] [Related]
5. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
6. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma.
Kurtin PJ
Adv Anat Pathol; 1998 Nov; 5(6):376-98. PubMed ID: 10095879
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Leukemic phase of mantle cell lymphoma, blastoid variant.
Singleton TP; Anderson MM; Ross CW; Schnitzer B
Am J Clin Pathol; 1999 Apr; 111(4):495-500. PubMed ID: 10191769
[TBL] [Abstract][Full Text] [Related]
10. The splenic form of mantle cell lymphoma.
Angelopoulou MK; Siakantariz MP; Vassilakopoulos TP; Kontopidou FN; Rassidakis GZ; Dimopoulou MN; Kittas C; Pangalis GA
Eur J Haematol; 2002 Jan; 68(1):12-21. PubMed ID: 11952817
[TBL] [Abstract][Full Text] [Related]
11. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
12. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
13. [Mantle cell lymphoma with marked lymphocytosis at the presentation and with discordant morphology between the lymph node and peripheral blood].
Isobe Y; Kawamata N; Sato N; Irie S; Kato A; Mori T; Hirano T; Oshimi K
Rinsho Ketsueki; 1998 Sep; 39(9):692-7. PubMed ID: 9796405
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome.
Molina TJ; Delmer A; Cymbalista F; Le Tourneau A; Perrot JY; Ramond S; Marie JP; Audouin J; Zittoun R; Diebold J
Virchows Arch; 2000 Dec; 437(6):591-8. PubMed ID: 11193469
[TBL] [Abstract][Full Text] [Related]
15. Splenic lymphoma with villous lymphocytes with CD5+, CD11c+ B-cell phenotype.
Miyawaki S; Machii T; Hirabayashi H; Sakura T; Shiozaki H; Yashiro K; Murakami H; Tsuchiya J; Kashiwabara K; Kitani T
Intern Med; 1993 Jun; 32(6):472-5. PubMed ID: 7694693
[TBL] [Abstract][Full Text] [Related]
16. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
[TBL] [Abstract][Full Text] [Related]
17. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
18. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
Sriganeshan V; Blom TR; Weissmann DJ
Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
[TBL] [Abstract][Full Text] [Related]
19. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
20. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]